<<

Datasheet Inhibitors / / Screening Libraries A DRUG SCREENING EXPERT

Product Name : Catalog Number : T3694 CAS Number : 198283-73-7 Molecular Formula : C9H11ClN2O Molecular Weight : 198.65

Description: Tebanicline (ABT-594, Ebanicline) acts as a partial at neuronal nicotinic receptors, binding to both the α3β4 and the α4β2 subtypes. Tebanicline is an effective synthetic nicotinic (non-) drug developed by Abbott. It was developed as a less toxic analog of the potent poison dart -derived compound , which is some 200x stronger than as an analgesic but produces extremely dangerous toxic side effects. Like epibatidine, Tebanicline showed potent analgesic activity against in both animal and human trials, but with far less toxicity than its parent compound.

Storage: 2 years -80°C in solvent; 3 years -20°C powder;

DMSO Soluble Solubility ( < 1 mg/ml refers to the product slightly soluble or insoluble )

Receptor (IC50) nAChR

Reference 1. Hayashi T, et al.Neurosci Lett. 2016 Dec 7;638:46-50. 2. Nirogi R. et al. Eur J Pharmacol. 2011 Oct 1;668(1-2):155-62.

FOR RESEARCH PURPOSES ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE. Information for product storage and handling is indicated on the product datasheet. Targetmol products are stable for long term under the recommended storage conditions. Our products may be shipped under different conditions as many of them are stable in the short-term at higher or even room temperatures. We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, please follow the storage recommendations on the product data sheet.

[email protected] | Tel: +1-781-999-4286 | www.targetmol.com